Tech Company Financing Transactions

Alexar Therapeutics Funding Round

Alexar Therapeutics, based in Malvern, secured $21.5 million in funding from New Science Ventures, Third Point and Palo Alto Investors.

Transaction Overview

Announced On
1/3/2014
Transaction Type
Venture Equity
Amount
$21,500,000
Round
Series A
Investors

New Science Ventures (Lead Investor) (Somu Subramaniam)

Third Point (Lead Investor) (Jason Hong)

Palo Alto Investors

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
101 Lindenwood Dr. 400
Malvern, PA 19355
USA
Email Address
Not Recorded
Overview
Alexar Therapeutics, Inc., headquartered in Malvern, Pennsylvania, is a privately held specialty pharmaceutical company .
Profile
Alexar Therapeutics LinkedIn Company Profile
Social Media
Alexar Therapeutics Company Twitter Account
Company News
Alexar Therapeutics News
Facebook
Alexar Therapeutics on Facebook
YouTube
Alexar Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Dave Pfeiffer
  Dave Pfeiffer LinkedIn Profile  Dave Pfeiffer Twitter Account  Dave Pfeiffer News  Dave Pfeiffer on Facebook
VP - R & D
Raju Mohan
  Raju Mohan LinkedIn Profile  Raju Mohan Twitter Account  Raju Mohan News  Raju Mohan on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/3/2014: Spredfast venture capital transaction
Next: 1/4/2014: ZeroTurnaround venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary